Is Madrigal Pharmaceuticals Inc (MDGL) a Winner in the Healthcare Sector?

A rating of 92 puts Madrigal Pharmaceuticals Inc (MDGL) near the top of the Healthcare sector according to InvestorsObserver. Madrigal Pharmaceuticals Inc's score of 92 means that it ranks higher than 92% of stocks in the sector. In addition, its overall score of 74 ranks it higher than 74% of all stocks.

MDGL has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on MDGL!

See Full MDGL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Madrigal Pharmaceuticals Inc Stock Today?

Madrigal Pharmaceuticals Inc (MDGL) stock is trading at $196.68 as of 11:09 AM on Friday, Nov 24, a gain of $6.20, or 3.25% from the previous closing price of $190.48. The stock has traded between $187.07 and $200.69 so far today. Volume today is light. So far 90,968 shares have traded compared to average volume of 443,780 shares. Click Here to get the full Stock Report for Madrigal Pharmaceuticals Inc stock.